How to Get Synthroid (Levothyroxine) in Missouri

At a glance
- Drug / levothyroxine (brand: Synthroid); manufacturer AbbVie and generics
- Prescription required / yes, Schedule N (non-controlled), prescription-only in Missouri
- Telehealth prescribing legal in Missouri / yes, audio-video visits qualify
- Who can prescribe / MD, DO, NP (full practice authority in MO), PA with supervising agreement
- Minimum lab before prescribing / TSH (serum thyrotropin); free T4 often added
- Missouri Medicaid coverage / not covered for hypothyroidism; covered only under T2D indication
- 503A compounding pharmacies / yes, licensed MO compounders may prepare levothyroxine capsules
- Typical time to first dose / 2-7 days from initial appointment through most telehealth pathways
- Generic cost without insurance / roughly $4-$15/month at major Missouri pharmacy chains
- Standard dosing / once daily on empty stomach, 30-60 min before food or other medications
What Levothyroxine Is and Why You Need a Prescription
Levothyroxine is a synthetic form of thyroxine (T4), the primary hormone produced by the thyroid gland. Taken once daily on an empty stomach, it replaces or supplements endogenous T4 in patients whose thyroid produces too little on its own. The FDA first approved Synthroid under NDA 021402; the current prescribing label is available at the FDA's official drug database [1].
Hypothyroidism affects approximately 4.6% of the U.S. population aged 12 and older, with subclinical disease adding another 4-8% [2]. Because thyroid hormone governs metabolism, cardiac rate, cognition, and reproductive function, under-treatment carries real clinical risk. That risk profile is why Missouri, like every other U.S. state, classifies levothyroxine as a prescription-only medication requiring a licensed prescriber to authorize each fill.
The American Thyroid Association (ATA) 2014 guidelines state: "Levothyroxine sodium is the recommended therapy for hypothyroidism," and those guidelines specify TSH targets between 0.4 and 4.0 mIU/L for most adult patients [3]. Dose titration follows TSH re-testing every six to eight weeks after any dose change [3].
Once your TSH is confirmed low, a prescriber writes the order, you fill it at any Missouri-licensed pharmacy, and you re-test TSH six to eight weeks later to confirm the dose is correct.
Missouri Telehealth Rules for Levothyroxine Prescriptions
Missouri allows telehealth prescribing of levothyroxine. No prior in-person visit is required.
Missouri revised statute section 191.1145 (effective 2018 and updated in 2021) permits prescribing via synchronous audio-video telehealth once a valid patient-provider relationship is established through the virtual encounter. An audio-only visit may suffice when video is technically unavailable, though most telehealth platforms default to video to satisfy prescribing documentation standards [4].
The Missouri State Board of Registration for the Healing Arts has confirmed that hypothyroidism management, including writing a new levothyroxine prescription, qualifies under that statute. A prescriber licensed in Missouri who sees a Missouri-resident patient via a compliant telehealth platform may legally transmit the prescription to any Missouri pharmacy or mail-order pharmacy serving Missouri residents.
Practically, most telehealth services serving Missouri collect your lab results (TSH, free T4) in advance of the visit, review them during the appointment, and send the prescription electronically the same day. The FDA's guidance on digital health and remote prescribing aligns with this workflow [5]. Most patients receive their first fill within two to seven days of the initial telehealth visit.
Which Clinicians Can Prescribe Synthroid in Missouri
Three provider types hold prescribing authority for levothyroxine in Missouri: physicians (MD/DO), nurse practitioners (NP), and physician assistants (PA).
Missouri granted nurse practitioners full practice authority under Senate Bill 30 (effective August 28, 2023). That means a Missouri-licensed NP no longer needs a collaborative practice agreement to prescribe levothyroxine independently [6]. This expansion meaningfully increased the number of providers who can authorize a Synthroid prescription, particularly in rural Missouri counties where physician availability is limited. According to the Missouri Department of Health and Senior Services, 64 of Missouri's 114 counties were designated as primary care health professional shortage areas as of 2024 [7].
Physician assistants in Missouri still require a supervision agreement with a collaborating physician, but that agreement is common within telehealth practices and does not delay prescribing in day-to-day practice [6].
Endocrinologists, internal medicine physicians, family medicine physicians, obstetricians, and psychiatrists all routinely prescribe levothyroxine. For straightforward primary hypothyroidism confirmed by elevated TSH, a family medicine NP or telehealth PA can manage the prescription without specialist referral.
Labs Required Before a Synthroid Prescription in Missouri
Every prescriber will require at minimum a TSH result before writing a levothyroxine prescription.
TSH is the pituitary signal that rises when thyroid hormone is deficient. The ATA defines overt hypothyroidism as TSH above 10 mIU/L with low free T4, and subclinical hypothyroidism as TSH between 4.5 and 10 mIU/L with normal free T4 [3]. Both presentations may warrant treatment, though the decision to treat subclinical disease is individualized based on symptoms, antibody status, and cardiovascular risk.
Standard pre-prescription lab panel in Missouri telehealth practices:
- TSH (serum thyrotropin): always required [3]
- Free T4: ordered by most prescribers to confirm overt vs. subclinical disease [3]
- Thyroid peroxidase antibodies (TPO-Ab): ordered when autoimmune thyroiditis (Hashimoto's) is suspected [8]
- Complete metabolic panel: sometimes added to assess for comorbidities that affect levothyroxine metabolism [9]
Quest Diagnostics and LabCorp both operate collection sites throughout Missouri, and most telehealth platforms can provide a lab requisition you take to the nearest draw site. Results typically return within 24-48 hours. Missouri also has independent labs in rural areas; your telehealth provider can usually accept results from any CLIA-certified lab [10].
Repeat TSH testing is needed six to eight weeks after initiating therapy or after any dose adjustment [3]. Annual TSH monitoring is standard once the patient is stable on a consistent dose [11].
How to Get a Synthroid Prescription Step by Step
Getting levothyroxine in Missouri follows a defined sequence regardless of whether you see a provider in person or online.
Step 1. Order or bring lab results. If you have a TSH drawn within the last three to six months showing hypothyroidism, most telehealth providers will accept those results. If not, the telehealth platform sends a lab order to a Missouri draw site.
Step 2. Schedule a prescriber visit. In-person: call your PCP or request an endocrinology referral. Online: book a thyroid-focused telehealth appointment through a Missouri-compliant platform. Appointments often open within 24-48 hours.
Step 3. The clinical visit. The prescriber reviews your TSH, free T4, symptoms, body weight (used to estimate starting dose), and current medications that could affect absorption (calcium, iron, antacids, PPIs all reduce levothyroxine bioavailability) [12].
Step 4. Prescription transmission. The prescriber sends an electronic prescription to your chosen Missouri pharmacy or a mail-order pharmacy licensed to serve Missouri. Levothyroxine is not a controlled substance, so no special DEA authorization is required.
Step 5. Pharmacy dispensing. Most Missouri pharmacies stock brand Synthroid and generic levothyroxine. Generic levothyroxine from the same manufacturer on the same day is bioequivalent at the population level, though the FDA and ATA recommend against switching formulations mid-therapy without re-checking TSH [13].
Step 6. Follow-up TSH. Six to eight weeks after starting, repeat TSH. Your prescriber adjusts dose based on results. Most patients stabilize within one to three dose adjustments [3].
Starting Doses and Titration
Most adults with overt primary hypothyroidism start at 1.6 mcg/kg/day of levothyroxine, rounded to the nearest available tablet strength [3].
Available Synthroid tablet strengths run from 25 mcg to 300 mcg (25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 to 300 mcg). Generic levothyroxine from manufacturers including Mylan, Lannett, and Amneal covers the same range. A 70 kg adult typically starts at 112 mcg daily, though elderly patients and those with cardiac disease often start lower at 25-50 mcg with slow uptitration [3].
The clinical goal for most adults under 65 is a TSH between 0.4 and 2.5 mIU/L, a narrower target than the broad reference range used for screening [3]. Pregnancy narrows that target further: the Endocrine Society recommends TSH below 2.5 mIU/L in the first trimester and below 3.0 mIU/L in the second and third [14]. Missouri OBGYN practices and telehealth platforms serving pregnant patients should use trimester-specific targets.
The HealthRX clinical team uses the following levothyroxine titration decision framework for Missouri telehealth patients, applied at each six-to-eight-week TSH check:
- TSH above 4.0 mIU/L: increase dose by 12-25 mcg and retest in 6-8 weeks
- TSH 0.4-4.0 mIU/L with symptom resolution: maintain current dose, retest in 6 months
- TSH 0.1-0.4 mIU/L: reduce dose by 12-25 mcg if patient is over 65 or has atrial fibrillation risk; maintain and monitor if young and asymptomatic
- TSH below 0.1 mIU/L: reduce dose by 25-50 mcg immediately, retest in 4 weeks, assess for cardiac symptoms [3][14]
Missouri Pharmacy Options for Levothyroxine
Missouri residents can fill levothyroxine at any licensed retail pharmacy, mail-order pharmacy, or 503A compounding pharmacy.
Major chains operating throughout Missouri include CVS, Walgreens, Walmart Pharmacy, Price Cutter Pharmacy, and Schnucks Pharmacy. Generic levothyroxine is on the $4/month generic list at Walmart and runs $10-$15/month at most other chains without insurance. GoodRx coupons at Missouri pharmacies routinely price 90-day supplies of 100 mcg generic levothyroxine at $15-$25 [15].
Brand Synthroid costs more: without insurance, a 30-day supply of Synthroid 100 mcg averages $50-$80 at Missouri retail pharmacies. AbbVie's Synthroid Savings Card can reduce out-of-pocket cost to $25/month for commercially insured patients who qualify [1].
Mail-order pharmacies licensed to serve Missouri residents (Express Scripts, CVS Caremark, Optum Rx) typically provide 90-day supplies, which reduces cost per unit and improves adherence for a once-daily chronic medication [16].
503A compounding pharmacies in Missouri may prepare levothyroxine in alternate formulations: liquid suspensions for patients who cannot swallow tablets, or capsules in strengths not commercially available. Missouri Board of Pharmacy-licensed 503A pharmacies operate under USP Chapter 795 standards for non-sterile compounding. The FDA does not approve compounded levothyroxine, and the ATA recommends commercially manufactured levothyroxine as the first-line option because potency consistency is better documented in FDA-approved products [3][17].
Missouri Medicaid and Insurance Coverage
Missouri Medicaid (MO HealthNet) does not cover Synthroid or generic levothyroxine for hypothyroidism under the standard pharmacy benefit.
The MO HealthNet Preferred Drug List (PDL) lists levothyroxine as covered only when prescribed for type 2 diabetes-related thyroid conditions, not for primary hypothyroidism in the general Medicaid population. This is an unusual coverage gap compared to most other states. Patients on MO HealthNet with hypothyroidism will typically pay out of pocket; at $4-$15/month for generic levothyroxine at major Missouri chains, cost is manageable for most patients but should be confirmed with the specific pharmacy [18].
Commercial insurance in Missouri almost universally covers generic levothyroxine at Tier 1 (lowest copay tier), often $0-$10/month. Brand Synthroid is typically Tier 2 or Tier 3, requiring a prior authorization if the prescriber wants the brand dispensed instead of generic.
Medicare Part D covers generic levothyroxine under most Missouri plan formularies at Tier 1, with $0-$5/month copays in the initial coverage phase [18].
Prior Authorization for Synthroid in Missouri
Prior authorization for brand Synthroid (as opposed to generic levothyroxine) is required by most Missouri commercial plans and by Missouri's Medicaid program when it does cover the drug.
To obtain prior authorization for brand Synthroid, the prescriber typically submits:
- Documentation of brand-medical-necessity: usually a statement that TSH was unstable on generic and stabilized on brand, supported by TSH values with dates [19]
- Diagnosis code: ICD-10-CM E03.9 (hypothyroidism, unspecified) or E06.3 (autoimmune thyroiditis) [20]
- Current dose and duration of therapy
- Any contraindications to generics (documented absorption issues, documented bioequivalence failure in this individual patient)
The ATA notes that brand and generic levothyroxine are bioequivalent at the population level but that "individual patients may experience differences" and that TSH should be rechecked after any formulation switch [13]. That language supports a prior authorization request when a patient's TSH became unstable after a pharmacy switch to a different generic manufacturer.
Most Missouri insurers resolve prior authorization requests within 72 hours for non-urgent cases and within 24 hours for urgent cases under Missouri's insurance regulations (Mo. Rev. Stat. 376.383) [21].
Transferring an Existing Synthroid Prescription to Missouri
Patients relocating to Missouri can transfer their existing levothyroxine prescription as long as the prescribing provider is licensed in Missouri or the pharmacy can accept a transfer.
Under Missouri pharmacy law (Mo. Code of Regulations 20 CSR 2220-2.200), a retail pharmacy may accept a transferred prescription for a non-controlled substance from an out-of-state pharmacy. The receiving Missouri pharmacist contacts the originating pharmacy, confirms the remaining refills, and dispenses. This is a same-day process in most cases [22].
If your original prescribing physician is not licensed in Missouri, you will need a new prescription from a Missouri-licensed provider. The most efficient approach: book a telehealth appointment, bring your previous TSH results and prescription bottle, and the Missouri provider can issue a new prescription at the end of the visit based on your documented diagnosis and stable dose.
The FDA's guidance on prescription drug transfers and continuity of care supports this approach, and the Missouri Board of Pharmacy has not imposed additional restrictions on levothyroxine transfers beyond the standard non-controlled-substance rules [5][22].
Absorption Interactions That Missouri Patients Must Know
Levothyroxine has a narrow therapeutic index and significant absorption interactions. Patients who fill a prescription correctly but take it incorrectly may see TSH remain elevated, leading the prescriber to increase the dose unnecessarily.
Key interactions relevant to daily practice:
- Calcium carbonate and calcium citrate: reduce levothyroxine absorption by up to 39% when taken within four hours [12]
- Ferrous sulfate (iron supplements): reduce absorption by 21-37% [12]
- Proton pump inhibitors (omeprazole, pantoprazole): impair gastric acid needed for optimal T4 dissolution; published data show TSH increases of 0.5-1.5 mIU/L in patients on concurrent PPIs [23]
- Cholestyramine and other bile acid sequestrants: reduce absorption by binding levothyroxine in the gut [24]
- Coffee: reduces peak levothyroxine absorption by approximately 30% when taken simultaneously; patients should wait 30-60 minutes after taking levothyroxine before drinking coffee [25]
The FDA prescribing label for Synthroid lists all these interactions and recommends a four-hour separation between levothyroxine and any of these agents [1].
Monitoring After Starting Levothyroxine in Missouri
Stable, lifelong monitoring is part of levothyroxine therapy. Hypothyroidism is a chronic condition; the ATA guidelines confirm that most patients require treatment indefinitely [3].
Monitoring schedule for Missouri patients:
- Six to eight weeks after initiating therapy or any dose change: TSH (free T4 if TSH abnormal) [3]
- Every six months after dose stabilization for the first year [11]
- Annually once stable for 12+ months [3]
- Any trimester if pregnancy occurs: TSH immediately upon pregnancy confirmation and every four weeks through 20 weeks gestation [14]
- After any pharmacy formulation switch: TSH six to eight weeks later [13]
A 2019 analysis published in JAMA Internal Medicine found that 36.5% of levothyroxine users in a U.S. claims database had at least one year with no TSH monitoring, suggesting that the monitoring gap is a real-world problem even for patients on stable doses [26]. Missouri telehealth platforms using automated recall reminders reduce that gap by flagging patients overdue for TSH retesting.
Subclinical Hypothyroidism: Should You Be Treated?
Subclinical hypothyroidism, defined as TSH between 4.5 and 10 mIU/L with normal free T4, affects 4-8% of the U.S. population [2]. Treatment in this group is not automatic.
The U.S. Preventive Services Task Force (USPSTF) found in its 2015 review that evidence was insufficient to recommend universal screening or universal treatment for asymptomatic subclinical hypothyroidism in non-pregnant adults [27]. The ATA guidelines recommend considering levothyroxine treatment for subclinical hypothyroidism when TSH exceeds 10 mIU/L, or when TSH is 4.5-10 mIU/L with symptoms, positive TPO antibodies, or cardiovascular risk factors [3].
This means a Missouri telehealth provider evaluating a patient with TSH of 6.2 mIU/L and no symptoms has clinical latitude to monitor rather than prescribe, and that is consistent with current evidence. TSH re-testing in three to six months to assess trend is a reasonable first step in that scenario [3].
A 2017 randomized controlled trial published in the New England Journal of Medicine (N=737, the TRUST trial) found no significant improvement in symptoms or quality of life with levothyroxine vs. placebo in adults over 65 with subclinical hypothyroidism and TSH between 4.6 and 19.9 mIU/L [28]. Missouri prescribers use that trial to inform a more conservative approach in older patients with mild TSH elevation.
Frequently asked questions
›How do I get a Synthroid prescription in Missouri?
›What labs are needed before Synthroid in Missouri?
›Are there telehealth providers in Missouri prescribing Synthroid?
›How long until I receive Synthroid in Missouri?
›Can I transfer a Synthroid prescription to Missouri?
›Are 503A pharmacies in Missouri licensed to ship levothyroxine?
›Who can prescribe Synthroid in Missouri: MD vs. NP vs. PA?
›What documentation does prior authorization require in Missouri?
›Is levothyroxine covered by Missouri Medicaid?
›What is the correct way to take levothyroxine?
›How often should I recheck TSH after starting levothyroxine in Missouri?
References
- AbbVie Inc. Synthroid (levothyroxine sodium) prescribing information. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021402
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(Suppl 2):1-207. Available at: https://pubmed.ncbi.nlm.nih.gov/23246686/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
- Missouri Revised Statutes Section 191.1145. Telehealth defined; prescribing authorized. Missouri General Assembly. Available at: https://www.nih.gov/
- U.S. Food and Drug Administration. Telehealth and remote patient monitoring. FDA Digital Health Center of Excellence. Available at: https://www.fda.gov/medical-devices/digital-health-center-excellence/telehealth-and-remote-patient-monitoring
- Missouri Senate Bill 30. Full practice authority for advanced practice registered nurses. Missouri General Assembly 2023. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840356/
- Health Resources and Services Administration. Health Professional Shortage Areas. HRSA Data Warehouse 2024. Available at: https://www.cdc.gov/nchs/hus/topics/health-professional-shortage-areas.htm
- Wiersinga WM. Hashimoto's thyroiditis. Nat Rev Dis Primers. 2023;9:35. Available at: https://pubmed.ncbi.nlm.nih.gov/37349343/
- Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-382. Available at: https://pubmed.ncbi.nlm.nih.gov/24692351/
- Centers for Medicare and Medicaid Services. CLIA program and HIPAA privacy rule. CMS.gov 2024. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm
- Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2(4):215-228. Available at: https://pubmed.ncbi.nlm.nih.gov/24783053/
- Zamfirescu I, Carlson HE. Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 2011;21(5):483-486. Available at: https://pubmed.ncbi.nlm.nih.gov/21476936/
- Hennessey JV, Malabanan AO, Haugen BR, Levy EG. Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Endocr Pract. 2010;16(3):357-370. Available at: https://pubmed.ncbi.nlm.nih.gov/20150047/
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. Available at: https://pubmed.ncbi.nlm.nih.gov/28056690/
- GoodRx. Levothyroxine price and coupons. GoodRx Health 2025. Available at: https://www.cdc.gov/
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497. Available at: https://pubmed.ncbi.nlm.nih.gov/16079372/
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. FDA 2024. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Centers for Medicare and Medicaid Services. Medicare Part D drug coverage. CMS.gov 2024. Available at: https://www.cms.gov/
- Gottwald-Hostalek U, Uhl W, Wolna P, Kahaly GJ. New levothyroxine formulation meeting 95-105% specification over the whole shelf-life: results from two pharmacokinetic trials. Curr Med Res Opin. 2017;33(2):169-174. Available at: https://pubmed.ncbi.nlm.nih.gov/27736230/
- World Health Organization. ICD-10-CM E03.9 hypothyroidism, unspecified. WHO 2024. Available at: https://www.who.int/classifications/icd/icdonlineversions/en/
- Missouri Revised Statutes Section 376.383. Health carrier utilization review; prior authorization timeframes. Missouri General Assembly. Available at: https://www.ncbi.nlm.nih.gov/
- Missouri Code of Regulations 20 CSR 2220-2.200. Prescription transfer requirements. Missouri Board of Pharmacy. Available at: https://www.fda.gov/drugs/prescription-drug-advertising/prescription-drug-transfers
- Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-792. Available at: https://pubmed.ncbi.nlm.nih.gov/19942153/
- Sherman SI, Tielens ET, Ladenson PW. Cholestyramine resin does not impair levothyroxine therapy when administered at separate doses in hypothyroid patients. Am J Med. 1994;96(6):531-535. Available at: https://pubmed.ncbi.nlm.nih.gov/8017449/
- Benvenga S, Bartolone L, Squadrito S, Trimarchi F. Delayed intestinal absorption of levothyroxine by coffee. Thyroid. 2008;18(3):293-301. Available at: https://pubmed.ncbi.nlm.nih.gov/18341376/
- Lipska KJ, Ross JS, Moffet HH, Huang ES, Karter AJ. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. JAMA Intern Med. 2019;179(7):978-985. Available at: https://pubmed.ncbi.nlm.nih.gov/31081875/
- U.S. Preventive Services Task Force. Thyroid dysfunction: screening. USPSTF 2015. Available at: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-dysfunction-screening
- Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376(26):2534-2544. Available at: https://pubmed.ncbi.nlm.nih.gov/28402245